A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis
Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of alendronate sodium vitamin D3 tablets
compared with placebo on the improvement of joint structure and joint pain in participants
with knee osteoarthritis. The treatment period of this study is one year and followed-up
period is 2 years. The results of knee joint MRI will be evaluated by using the WORMS score.